Abstract
We have determined that the organic matrix of calcium oxalate kidney stones contains a glycoprotein inhibitor of calcium oxalate crystal growth (nephrocalcin) that resembles nephrocalcin present in the urine of patients with calcium oxalate stones and differs from nephrocalcin from the urine of normal people. Pulverized calcium oxalate renal stones were extracted with 0.05 M EDTA, pH 8.0; nephrocalcin eluted in five peaks using DEAE-cellulose column chromatography, and each peak was further resolved by Sephacryl S-200 column chromatography. Four of the five DEAE peaks corresponded to those usually found in nephrocalcin from urine; the fifth eluted at a lower ionic strength than any found in urine. Amino acid compositions and surface properties of nephrocalcins isolated from kidney stones closely resembled those of nephrocalcins isolated from urine of stone-forming patients: they differed from normal in lacking gamma-carboxyglutamic acid residues, and in forming air-water interfacial films that were less stable than those formed by nephrocalcin from normal urine.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Deganello S., Chou C. The uric acid-whewellite association in human kidney stones. Scan Electron Microsc. 1984;(Pt 2):927–933. [PubMed] [Google Scholar]
- Hauschka P. V. Quantitative determination of gamma-carboxyglutamic acid in proteins. Anal Biochem. 1977 May 15;80(1):212–223. doi: 10.1016/0003-2697(77)90640-6. [DOI] [PubMed] [Google Scholar]
- Ito H., Coe F. L. Acidic peptide and polyribonucleotide crystal growth inhibitors in human urine. Am J Physiol. 1977 Nov;233(5):F455–F463. doi: 10.1152/ajprenal.1977.233.5.F455. [DOI] [PubMed] [Google Scholar]
- Lian J. B., Prien E. L., Jr, Glimcher M. J., Gallop P. M. The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest. 1977 Jun;59(6):1151–1157. doi: 10.1172/JCI108739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakagawa Y., Abram V., Coe F. L. Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine. Am J Physiol. 1984 Nov;247(5 Pt 2):F765–F772. doi: 10.1152/ajprenal.1984.247.5.F765. [DOI] [PubMed] [Google Scholar]
- Nakagawa Y., Abram V., Kézdy F. J., Kaiser E. T., Coe F. L. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem. 1983 Oct 25;258(20):12594–12600. [PubMed] [Google Scholar]
- Nakagawa Y., Abram V., Parks J. H., Lau H. S., Kawooya J. K., Coe F. L. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct;76(4):1455–1462. doi: 10.1172/JCI112124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakagawa Y., Margolis H. C., Yokoyama S., Kézdy F. J., Kaiser E. T., Coe F. L. Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem. 1981 Apr 25;256(8):3936–3944. [PubMed] [Google Scholar]
- Warpehoski M. A., Buscemi P. J., Osborn D. C., Finlayson B., Goldberg E. P. Distribution of organic matrix in calcium oxalate renal calculi. Calcif Tissue Int. 1981;33(3):211–222. doi: 10.1007/BF02409440. [DOI] [PubMed] [Google Scholar]